Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

toothbrush

- PMLiVE

Jardiance is first diabetes drug to improve CV outcomes

Lilly/Boehringer drug could gain market share boost from new data

- PMLiVE

Intarcia’s diabetes implant beats Merck’s Januvia in trial

New injection-less therapy could revolutionise diabetes treatment

Celgene building

Myeloma market set to be $9bn by 2021

New research shows it will pushed by a growing prevalence of the disease

- PMLiVE

Valeant swoops on Sprout to claim female sexual disorder drug

Comes in the same week that firm gained US approval for its ‘little pink pill’

Two behavioural change contract wins for Hamell

Agency will work on segmentation and promotional projects

- PMLiVE

Lundbeck to cut 1,000 jobs in major restructure

Losses will be felt in its headquarter functions and commercial operations

Innovating with what you have: better healthcare with existing technology

Senior Account Executive Will Taylor talks us through a case study in applying established technology to healthcare problems in an innovative way.

Blue Latitude Health

- PMLiVE

Sudler London makes three senior hires

Mark Boulding, Jason Galla-Barth and Abbie Pound will boost its London office

- PMLiVE

Cube Creative moves offices and expands team

Manchester agency appoints Will Stone and Gemma Beharry

- PMLiVE

Rebuffed Horizon tries to replace Depomed board members

But firm says latest deal 'significantly undervalues' Depomed

- PMLiVE

EU green light for Novartis’ skin cancer therapy

Swiss firm’s basal cell carcinoma treatment can now be launched across Europe

- PMLiVE

FDA slams Kardashian West’s Instagram drug promotion

Morning-sickness drug firm Duchesnay criticised over social media marketing

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links